Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$25.26 - $29.6 $194,628 - $228,068
7,705 New
7,705 $215,000
Q3 2022

Nov 08, 2022

BUY
$43.76 - $53.42 $43 - $53
1 Added 0.22%
460 $20,000
Q2 2022

Aug 09, 2022

BUY
$46.53 - $55.17 $511 - $606
11 Added 2.46%
459 $24,000
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $786,351 - $974,387
-17,188 Reduced 97.46%
448 $23,000
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $728,719 - $1.08 Million
17,636 New
17,636 $1.04 Million
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $2.33 Million - $2.62 Million
-69,455 Closed
0 $0
Q4 2020

Feb 05, 2021

BUY
$33.47 - $42.56 $931,135 - $1.18 Million
27,820 Added 66.82%
69,455 $2.56 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $3,048 - $3,576
-96 Reduced 0.23%
41,635 $1.53 Million
Q2 2020

Aug 10, 2020

BUY
$30.12 - $36.54 $1.26 Million - $1.52 Million
41,731 New
41,731 $1.37 Million
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $106,795 - $152,587
-3,951 Closed
0 $0
Q4 2019

Feb 06, 2020

SELL
$32.92 - $37.36 $192,384 - $218,331
-5,844 Reduced 59.66%
3,951 $155,000
Q3 2019

Nov 06, 2019

BUY
$32.49 - $42.13 $164,626 - $213,472
5,067 Added 107.17%
9,795 $352,000
Q2 2019

Aug 08, 2019

SELL
$36.98 - $41.52 $228,906 - $257,008
-6,190 Reduced 56.7%
4,728 $205,000
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $1.53 Million - $1.68 Million
-40,896 Reduced 78.93%
10,918 $463,000
Q4 2018

Feb 07, 2019

BUY
$38.47 - $43.86 $1.56 Million - $1.78 Million
40,639 Added 363.66%
51,814 $2.26 Million
Q3 2018

Nov 08, 2018

BUY
$34.47 - $41.81 $150,599 - $182,667
4,369 Added 64.19%
11,175 $492,000
Q2 2018

Aug 07, 2018

SELL
$32.98 - $35.16 $483,618 - $515,586
-14,664 Reduced 68.3%
6,806 $246,000
Q1 2018

May 18, 2018

BUY
$31.91 - $37.02 $94,613 - $109,764
2,965 Added 16.02%
21,470 $762,000
Q4 2017

Feb 08, 2018

BUY
$33.26 - $35.29 $615,476 - $653,041
18,505
18,505 $670,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Rational Advisors LLC Portfolio

Follow Rational Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rational Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rational Advisors LLC with notifications on news.